BMRN vs MESO
BioMarin Pharmaceutical Inc. · Mesoblast Limited
Relative return (rebased to 100)
Key stats
| Metric | BMRN | MESO |
|---|---|---|
| Price | $54.80 | $14.29 |
| Market Cap | $10.61B | $18.53B |
| P/E | 30.40 | — |
| P/B | 1.68 | 32.25 |
| P/S | 3.29 | 1077.58 |
| ROE | 5.5% | -17.8% |
| Net Margin | 10.8% | -593.9% |
| Gross Margin | — | — |
| Revenue Growth | 12.9% | 191.4% |
| Dividend Yield | — | — |
| EPS | $1.80 | -$0.08 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.